The medicine
"Glybomet" refers to
instructions for use in the group
of combined
hypoglycemic drugs . The basis of the action of this tool is to stimulate the secretion of endogenous insulin and a significant increase in the utilization of glucose by the muscle tissue. All these processes result in a pronounced
synergistic effect, due to which the risk of developing functional pancreatic insufficiency and the likelihood of undesirable side effects are reduced. Among other things, the Glibomet preparation has a characteristic cardioprotective antiarrhythmic effect and reduces
platelet aggregation, which ultimately helps to prevent vascular complications of diabetes.
This hypoglycemic medicine is produced in the form of round dragees of a white shade. Each Glibomet tablet contains metformin hydrochloride and glibenclamide, which act as active components. Auxiliary elements are gelatin, MCC, finely divided silica , corn starch, magnesium stearate, glycerin, diethyl phthalate, cellulose acetate phthalate and talc.
To take the hypoglycemic drug Glybomet, the instructions for use advise exclusively if monotherapy with oral medications or diet therapy is ineffective for the treatment of non-insulin-dependent type 2 diabetes mellitus. In addition, the manufacturer recommends prescribing these tablets with a decrease in sensitivity to sulfonylureas due to their prolonged use.
To take the medicine "Glibomet" the instructions for use, which are included in the kit, categorically prohibits in the event that the patient has an allergic reaction to metformin or glibenclamide, as well as individual intolerance to any of the auxiliary elements present in the composition. In addition, the list of direct contraindications also includes ketoacidosis, insulin-dependent and latent forms of
diabetes, diabetic precoma and coma. Patients with severe pathologies in the liver or kidneys, respiratory failure, severe heart disease or adrenal cortex insufficiency should also refuse to take the Glybomet hypoglycemic drug. Instructions for use do not recommend using these tablets during fasting, in case of chronic alcoholism, gangrene, dystrophy or in a state of shock. An established pregnancy or suspected pregnancy is also a reason for discontinuing this medicine. And finally, it is not allowed to take this drug for acute heavy bleeding and during lactation.
As for the undesirable reactions and possible side effects, the appearance of which can often be caused by taking Glybomet tablets, the risk of hypoglycemia, cholestatic jaundice or hepatitis should be highlighted here first. In addition, some people using this remedy may experience conditions such as vomiting, headache, weakness, sensory disturbances, urticaria, paresis, muscle cramps, megaloblastic or hemolytic anemia, joint pain.